A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer
Clinical trial NCT06163391 · RECRUITING
Trial details
- NCT number
- NCT06163391
- Sponsor
- SOTIO Biotech AG
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.